Target intelligence / Profile preview

Protein catabolism

Molecular classification
Other (biochemical process), Enzymatic pathway
01

Overview

Protein catabolism is the process by which proteins are enzymatically broken down into peptides and amino acids, primarily via proteases such as pepsin, trypsin, and chymotrypsin. This process is essential for the recycling of cellular proteins, the absorption of dietary protein, and normal metabolic functioning. The amino acids released are either reused for new protein synthesis, metabolized for energy, or converted into other biomolecules. Catabolism occurs in multiple stages: initial digestion by gastrointestinal enzymes, further cleavage by pancreatic proteases, and final breakdown in cellular lysosomes. Protein catabolism is regulated by multiple factors including the ubiquitin-proteasome system and various forms of post-translational modification (e.g. phosphorylation and ubiquitination). Dysregulation of protein catabolism can contribute to disease pathogenesis, making individual components (such as specific proteases) potential therapeutic targets, but the process itself is not a discrete molecular target.

Other names
Protein degradationProtein breakdownProteolysis
02

Mechanism of action

Inhibition of proteases (blocks protein breakdown) Modulation of ubiquitin-proteasome system (regulates protein degradation pathway) Alteration of lysosomal function

03

Biological functions

Cellular turnoverDigestionMetabolismRecycling of amino acidsEnergy productionApoptosis (cell death)Regulation of protein levels
04

Disease associations

Cancer (aberrant protein catabolism in tumors)InflammationNeurodegenerative disease (excessive protein degradation or impaired proteostasis)Cachexia (wasting syndrome)Metabolic disordersInfection (pathogen-driven proteolysis)
05

Safety considerations

Inhibition of protein catabolism can lead to unwanted accumulation of damaged/misfolded proteinsExcessive protein catabolism contributes to muscle wasting and cachexiaDisruption may cause metabolic imbalances (e.g. altered ammonia/urea detoxification)
06

Interacting drugs

Protease inhibitors (e.g. bortezomib, used in cancer)

1 more in the full profile.

07

Biomarkers

Ubiquitin (tag for proteins destined for catabolic degradation)Proteasome activity levelsSerum amino acid profilesAmmonia and urea (byproducts of protein catabolism)

Beyond the preview

Go deeper on Protein catabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein catabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call